240
Participants
Start Date
October 8, 2019
Primary Completion Date
April 9, 2020
Study Completion Date
April 9, 2020
MMH-407
Oral use.
Placebo
Oral use.
Central Clinical Hospital of the Russian Academy of Sciences, Moscow
Moscow State Medical and Dental University named after A.I. Evdokimov, Pulmonology Laboratory, Moscow
Podolsk City Clinical Hospital # 3, Podolsk
Vvedensky City Clinical Hospital, Saint Petersburg
City Polyclinic #25 of the Nevsky District, Saint Petersburg
"Medical Center Reavita Med SPb", Saint Petersburg
Road Clinical Hospital of JSC Russian Railways, Saint Petersburg
City Polyclinic #51, Saint Petersburg
City Polyclinic #34, Saint Petersburg
City Polyclinic #43, Saint Petersburg
Belgorod State National Research University, Hospital Therapy Department, Belgorod
City Emergency Hospital Rostov-on-Don, Rostov-on-Don
Kuban State Medical University, Infectious Diseases and PhthisiopulmonologyDepartment, Krasnodar
Scientific Medical Center for General Therapy and Pharmacology, Stavropol
Ryazan State Medical University named after academician I.P. Pavlov, Department of Outpatient Therapy and Preventive Medicine, Ryazan
Volgograd State Medical University, Volgograd
Kazan State Medical University, Internal Medicine Department, Kazan'
Kazan State Medical University, Professorial clinic, Kazan'
City Clinical Hospital #9 of the Ministry of Health of the Udmurt Republic, Izhevsk
Samara City Hospital #4, Samara
Bashkir State Medical University, Internal Medicine Department, Ufa
Road Clinical Hospital at Chelyabinsk station of JSC Russian Railways, Chelyabinsk
City Clinical Hospital #10 of the Kanavinsky District of Nizhny Novgorod, Nizhny Novgorod
Road Clinical Hospital at the station Nizhny Novgorod of JSC Russian Railways, Nizhny Novgorod
Altai State Medical University, Department of Faculty Therapy with a course of immunology and allergology, Barnaul
City Hospital #5, Barnaul
Lead Sponsor
Materia Medica Holding
INDUSTRY